Literature DB >> 18199542

p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein.

Ya-Wen Chen1, Seema Paliwal, Kyle Draheim, Steven R Grossman, Brian C Lewis.   

Abstract

The INK4A/ARF tumor suppressor locus is frequently inactivated in hepatocellular carcinoma (HCC), yet the consequences of this remain unknown. We recently described a HCC mouse model in which loss of the Ink4a/Arf locus accelerates the development of metastasis and enhances tumor cell migration and invasion in cell culture assays. We show here that knockdown of p19Arf in an HCC cell line increases invasion in cell culture assays. Furthermore, reintroduction of p19(Arf) into HCC cell lines lacking Ink4a/Arf inhibits tumor cell invasion, without affecting cell proliferation, or cell transformation as measured by soft agar colony formation. Inhibition of cell invasion by p19(Arf) was dependent on its C-terminal binding protein (CtBP) interaction domain but independent of Mdm2 binding and nucleolar localization. Indeed, RNA interference-mediated knockdown of CtBP1 or CtBP2 decreased cell invasion, and ectopic expression of CtBP2 enhanced tumor cell migration and invasion. Thus, our data indicate a novel role for the Arf tumor suppressor protein in regulating phenotypes associated with tumor progression and metastasis in HCC cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199542      PMCID: PMC2376045          DOI: 10.1158/0008-5472.CAN-07-1960

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  p19ARF targets certain E2F species for degradation.

Authors:  F Martelli; T Hamilton; D P Silver; N E Sharpless; N Bardeesy; M Rokas; R A DePinho; D M Livingston; S R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Evidence for a function of CtBP in epithelial gene regulation and anoikis.

Authors:  M L Grooteclaes; S M Frisch
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

3.  p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.

Authors:  Fukun Guo; Yuan Gao; Lei Wang; Yi Zheng
Journal:  J Biol Chem       Date:  2003-02-10       Impact factor: 5.157

4.  p19ARF directly and differentially controls the functions of c-Myc independently of p53.

Authors:  Ying Qi; Mark A Gregory; Zhaoliang Li; Jeffrey P Brousal; Kimberly West; Stephen R Hann
Journal:  Nature       Date:  2004-09-08       Impact factor: 49.962

Review 5.  Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.

Authors:  Z Y Tang; F X Sun; J Tian; S L Ye; Y K Liu; K D Liu; Q Xue; J Chen; J L Xia; L X Qin; S L Sun; L Wang; J Zhou; Y Li; Z C Ma; X D Zhou; Z Q Wu; Z Y Lin; B H Yang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 6.  Hepatocellular carcinoma: current surgical management.

Authors:  Tae-Jin Song; Edmund Wai Kit Ip; Yuman Fong
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 7.  CtBP, an unconventional transcriptional corepressor in development and oncogenesis.

Authors:  G Chinnadurai
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

8.  INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.

Authors:  A Tannapfel; C Busse; L Weinans; M Benicke; A Katalinic; F Geissler; J Hauss; C Wittekind
Journal:  Oncogene       Date:  2001-10-25       Impact factor: 9.867

Review 9.  Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.

Authors:  Marie Annick Buendia
Journal:  Med Pediatr Oncol       Date:  2002-11

10.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

View more
  37 in total

1.  The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.

Authors:  Viviane Palhares Muniz; J Matthew Barnes; Seema Paliwal; Xuefeng Zhang; Xiaoyun Tang; Songhai Chen; Kokou D Zamba; Joseph J Cullen; David K Meyerholz; Shari Meyers; J Nathan Davis; Steven R Grossman; Michael D Henry; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2011-06-02       Impact factor: 5.852

2.  Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).

Authors:  Sudha Korwar; Benjamin L Morris; Hardik I Parikh; Robert A Coover; Tyler W Doughty; Ian M Love; Brendan J Hilbert; William E Royer; Glen E Kellogg; Steven R Grossman; Keith C Ellis
Journal:  Bioorg Med Chem       Date:  2016-04-20       Impact factor: 3.641

3.  Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.

Authors:  Y Zhao; C Zhang; X Yue; X Li; J Liu; H Yu; V A Belyi; Q Yang; Z Feng; W Hu
Journal:  Cell Death Differ       Date:  2015-04-10       Impact factor: 15.828

4.  Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in Hepatocarcinogenesis.

Authors:  Robyn P Strauss; Katherine M Audsley; Adam M Passman; Joanne H van Vuuren; Megan L Finch-Edmondson; Bernard A Callus; George C Yeoh
Journal:  Gene Expr       Date:  2020-04-21

5.  Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.

Authors:  S-H Wang; J S Chang; J-R Hsiao; Y-C Yen; S S Jiang; S-H Liu; Y-L Chen; Y-Y Shen; J-Y Chang; Y-W Chen
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

6.  Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis.

Authors:  Da-Qiang Li; Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Jun-Xiang Zhang; Lei Wang; Yanping Zhang; Ignacio Moreno de Alborán; M Radhakrishna Pillai; Jeyanthy Eswaran; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

7.  High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.

Authors:  Xiancheng Liu; Ninghua Yao; Jing Qian; Huiwei Huang
Journal:  Med Oncol       Date:  2014-02-13       Impact factor: 3.064

8.  Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.

Authors:  Charles N Birts; Rachael Harding; Gehan Soosaipillai; Trisha Halder; Ali Azim-Araghi; Matthew Darley; Ramsey I Cutress; Adrian C Bateman; Jeremy P Blaydes
Journal:  Biol Cell       Date:  2010-01       Impact factor: 4.458

Review 9.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

10.  CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1.

Authors:  Seema Paliwal; Ngoc Ho; Daniel Parker; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.